Robert L. Cody

1.1k total citations
19 papers, 899 citations indexed

About

Robert L. Cody is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert L. Cody has authored 19 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert L. Cody's work include Glycosylation and Glycoproteins Research (2 papers), Global Cancer Incidence and Screening (2 papers) and Virus-based gene therapy research (2 papers). Robert L. Cody is often cited by papers focused on Glycosylation and Glycoproteins Research (2 papers), Global Cancer Incidence and Screening (2 papers) and Virus-based gene therapy research (2 papers). Robert L. Cody collaborates with scholars based in United States and Poland. Robert L. Cody's co-authors include Gary D. Hutchins, Richard L. Wahl, Michael S. Simon, Max S. Wicha, P.V. Dilts, Alfred E. Chang, Michael P. Hopkins, Dorit D. Adler, L.J. Pierce and Mark A. Helvie and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Cancer.

In The Last Decade

Robert L. Cody

19 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert L. Cody United States 12 344 247 192 139 134 19 899
Feig Sa United States 19 168 0.5× 301 1.2× 226 1.2× 128 0.9× 97 0.7× 55 955
Anuradha Chakravarthy United States 13 415 1.2× 153 0.6× 310 1.6× 170 1.2× 128 1.0× 25 950
Laurent H. Schwartz France 13 232 0.7× 135 0.5× 321 1.7× 265 1.9× 147 1.1× 16 896
W. E. C. Allt Canada 9 127 0.4× 234 0.9× 194 1.0× 161 1.2× 90 0.7× 11 675
Carolina Marini Italy 13 420 1.2× 256 1.0× 293 1.5× 154 1.1× 333 2.5× 27 1.9k
Daniel A. Savino United States 13 767 2.2× 350 1.4× 230 1.2× 106 0.8× 136 1.0× 19 1.7k
Russell Burcombe United Kingdom 10 297 0.9× 255 1.0× 245 1.3× 98 0.7× 77 0.6× 24 733
Hywel Madoc‐Jones United States 20 275 0.8× 85 0.3× 276 1.4× 213 1.5× 259 1.9× 43 1.4k
Kaiyumars Contractor United Kingdom 16 534 1.6× 203 0.8× 238 1.2× 236 1.7× 126 0.9× 22 944
Nina Einhorn Sweden 22 207 0.6× 205 0.8× 359 1.9× 240 1.7× 272 2.0× 56 1.9k

Countries citing papers authored by Robert L. Cody

Since Specialization
Citations

This map shows the geographic impact of Robert L. Cody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Cody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Cody more than expected).

Fields of papers citing papers by Robert L. Cody

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Cody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Cody. The network helps show where Robert L. Cody may publish in the future.

Co-authorship network of co-authors of Robert L. Cody

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Cody. A scholar is included among the top collaborators of Robert L. Cody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Cody. Robert L. Cody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cody, Robert L., et al.. (2007). Metastatic adrenocortical oncocytoma: A case report. Urologic Oncology Seminars and Original Investigations. 26(2). 198–201. 25 indexed citations
2.
Talsma, AkkeNeel, Anne Richter, Thomas Tsai, et al.. (2005). Rapid-cycle improvement in quality of care for patients hospitalized with acute myocardial infarction or heart failure: moving from a culture of missed opportunity to a system of accountability.. PubMed. 16(1). 14–9. 4 indexed citations
3.
Helvie, Mark A., L K Joynt, Robert L. Cody, et al.. (1996). Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy.. Radiology. 198(2). 327–332. 74 indexed citations
4.
Huhn, Richard D., Edward J. Yurkow, Robert Tushinski, et al.. (1996). Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.. PubMed. 24(7). 839–47. 34 indexed citations
5.
Natale, Ronald B., Robert L. Cody, Michael S. Simon, & Richard Wheeler. (1993). An in vivo and in vitro trial of aclarubicin in metastatic breast cancer: a novel approach to the study of analogs. Cancer Chemotherapy and Pharmacology. 31(6). 485–488. 6 indexed citations
6.
August, David A., Jay K. Harness, Robert L. Cody, et al.. (1993). Benefits of a multidisciplinary approach to breast care. Journal of Surgical Oncology. 53(3). 161–167. 22 indexed citations
7.
Cody, Robert L., David Stewart, Malcolm Moore, et al.. (1993). Multicenter Phase II Study of Brequinar Sodium in Patients with Advanced Breast Cancer. American Journal of Clinical Oncology. 16(6). 526–528. 36 indexed citations
8.
Cody, Robert L., et al.. (1992). Phase II trial of N-methylformamide in lung cancer. Investigational New Drugs. 10(3). 215–216. 3 indexed citations
9.
Cody, Robert L. & Marion Slack. (1992). Crossover Design in Pharmacy Research. Annals of Pharmacotherapy. 26(3). 327–333. 4 indexed citations
10.
Simon, Michael S. & Robert L. Cody. (1992). Cellulitis after axillary lymph node dissection for carcinoma of the breast. The American Journal of Medicine. 93(5). 543–548. 78 indexed citations
11.
Dilts, P.V., Michael P. Hopkins, Alfred E. Chang, & Robert L. Cody. (1992). Rapid growth of leiomyoma in patient receiving tamoxifen. American Journal of Obstetrics and Gynecology. 166(1). 167–168. 60 indexed citations
12.
Farnen, John P., et al.. (1991). Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro.. PubMed. 5(7). 574–84. 4 indexed citations
13.
14.
Waterhouse, David, Ronald B. Natale, & Robert L. Cody. (1991). Breast cancer and paraneoplastic cerebellar degeneration. Cancer. 68(8). 1835–1841. 26 indexed citations
15.
Nichols, William C., Susan E. Lyons, Jonathan S. Harrison, Robert L. Cody, & David Ginsburg. (1991). Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.. Proceedings of the National Academy of Sciences. 88(9). 3857–3861. 46 indexed citations
16.
Gribbin, Thomas, Constance K. Stein, Jonathan S. Harrison, et al.. (1989). Association of a mature B cell leukemia with a 4p+ chromosomal abnormality: derivation and characterization of a cell line.. PubMed. 3(9). 643–7. 5 indexed citations
17.
Cody, Robert L., et al.. (1989). Production of Mammastatin, a Tissue-Specific Growth Inhibitor, by Normal Human Mammary Cells. Science. 244(4912). 1585–1587. 67 indexed citations
18.
Cody, Robert L. & Max S. Wicha. (1986). Clustering of cell surface laminin enhances its association with the cytoskeleton. Experimental Cell Research. 165(1). 107–116. 46 indexed citations
19.
Lausch, Robert N., et al.. (1971). Host response to challenge with SA7‐induced autochthonous tumor cells. International Journal of Cancer. 8(1). 10–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feig Sa Breakdown of academic impact, for papers by Anuradha Chakravarthy Breakdown of academic impact, for papers by Laurent H. Schwartz Breakdown of academic impact, for papers by W. E. C. Allt Breakdown of academic impact, for papers by Carolina Marini Breakdown of academic impact, for papers by Daniel A. Savino Breakdown of academic impact, for papers by Russell Burcombe Breakdown of academic impact, for papers by Hywel Madoc‐Jones Breakdown of academic impact, for papers by Kaiyumars Contractor Breakdown of academic impact, for papers by Nina Einhorn
Rankless by CCL
2026